Journal Guide

Epilepsia Open publishes original research in all aspects of epilepsy, making it widely available through Open Access publication. Epilepsia Open is the new open access journal of the International League Against Epilepsy (ILAE). The primary aim of Epilepsia Open is to rapidly publish robust high quality results that provide insights in all aspects of epilepsy research. Specifically, Epilepsia Open will publish peer reviewed, high quality open access articles covering the entire breadth of basic, translational and clinical research in epilepsy. The spectrum of articles may include all disciplines of life and health sciences, such as public/global health science and societal impact studies. Epilepsia Openalso welcomes submissions of high quality research with confirmatory results, failure-to-confirm studies, and negative results or interesting study protocols for testing new treatments. Epilepsia Open will publish communications from the ILAE and its Chapters. A priority is also given to commentaries of issues and concepts that enhance the access and application of basic research findings for clinical scientists and health professionals, and promote a better understanding of clinical challenges for biomedical researchers. Epilepsia Open is creating a unique forum for the reputable and speedy open access publication of epilepsy research. We are committed to facilitating and invigorating a robust and successful pipeline for improved human health science in epilepsy.

JCI Insight is a peer-reviewed journal dedicated to biomedical research, ranging from preclinical to clinical studies.

JCI Insight publishes well-executed, high-quality, insightful research in all biomedical specialties, including Autoimmunity, Gastroenterology, Immunology, Metabolism, Nephrology, Neuroscience, Oncology, Pulmonology, Vascular Biology, and many others.

Papers submitted to JCI Insight should present a focused line of investigation that provides meaningful and impactful contributions to the understanding of the biology of disease or new therapeutic opportunities. JCI Insight articles may build on existing paradigms in the field or provide hypothesis-generating findings. Examples of studies suitable for JCI Insight include, but are not limited to, human genetics research, new mouse models of disease, in vivo studies of disease mechanisms, precision medicine, clinical and biomarker studies, and studies that provide new resources for the biomedical research community. Studies should include a relevant in vivo model system and/or a primary human cell or tissue model.

JCI Insight builds on the editorial leadership of the JCI, one of the oldest and most respected biomedical research journals, and is published by the American Society for Clinical Investigation (ASCI), a nonprofit honor organization of physician-scientists incorporated in 1908. JCI Insight serves to fulfill the ASCI’s objective to advance medical science through the publication of clinically relevant research reports. All articles published in JCI Insight are freely available online from the moment of publication.

TRB is one of six major divisions of the National Research Council, which serves as an independent adviser to the federal government and others on scientific and technical questions of national importance, and which is jointly administered by the National Academy of Sciences, the National Academy of Engineering, and the Institute of Medicine. The mission of the Transportation Research Board is to provide leadership in transportation innovation and progress through research and information exchange, conducted within a setting that is objective, interdisciplinary, and multimodal. The Board is supported by state transportation departments, federal agencies including the component administrations of the U.S. Department of Transportation, and other organizations and individuals interested in the development of transportation.Each year, TRB’s varied activities engage more than 7,000 engineers, scientists, and other transportation researchers and practitioners from the public and private sectors and academia, all of whom contribute their expertise in the public interest by participating on TRB committees, panels, and task forces. Others get involved and support TRB activities by becoming a TRB Affiliate; participating in TRB-sponsored conferences and workshops; authoring technical papers and contract research reports; and more.Here are links to additional information on how you can get involved in TRB.

Early Education and Development (EE&D) is a professional journal for those involved in educational and preschool services and research related to children and their families: early education supervisors, school psychologists, daycare administrators, child development specialists, developmental and child clinical psychologists, and special education administrators. It is designed to emphasize the implications for practice of research and solid scientific information. The age range focused upon is preschool through the primary grades.EE&D is a connecting link between the research community in early education and child development and school district early education programs, daycare systems, and special needs preschool programs. It is a publication established as a continuing forum for research and general policy articles in the rapidly growing area of early education services for the preschool child.The scope of Early Education and Development includes: children with disabilities, preschool and childcare programs, research on remedial programs, instructional and developmental techniques, school district and community policies, kindergarten screening, assessment devices and approaches, parental role and competencies, staff competencies, social and physical environment, school readiness, and early education and intervention. Peer Review Policy: All research articles in this journal have undergone rigorous peer review, based on initial editor screening and anonymous refereeing by at least two anonymous referees. Insofar as authors follow our instruction to completely blind their submissions, all review is double-blind. Publication office: Taylor & Francis, Inc., 325 Chestnut Street, Suite 800, Philadelphia, PA 19106.

Essential ReadingThe Journal of Psychopharmacology is a fully peer-reviewed, international journal that publishes original research and review articles on preclinical and clinical aspects of psychopharmacology. The journal provides an essential forum for researchers and practicing clinicians on the effects of drugs on animal and human behavior, and the mechanisms underlying these effects.International ForumThe Journal of Psychopharmacology is truly international in scope and readership. This is reflected by its editorial board which has brought together the very best of clinical and preclinical psychopharmacology from around the world.Regular FeaturesPublished monthly, the Journal of Psychopharmacology provides readers with an extensive array of regular features, including: * Original Research - original scientific papers addressing preclinical and clinical aspects of psychopharmacology * Critique - papers on topics of general interest and importance written by experts, commentaries by other authorities and their rejoinders provide the reader with a rounded understanding of the issues involved * Perspectives - pithy, thought-provoking, short and focused reviews * Letters - facilitating an ongoing dialogue on key issues of psychopharmacology, the letters address issues raised by published articles, or report significant new findings that merit rapid dissemination The Journal of Psychopharmacology is published monthly. The Journal regularly includes supplementary issues for subscribers at no extra cost. A Full Range of Custom Services The Journal of Psychopharmacology provides an excellent international platform from which to present important clinical and pre-clinical research and an effective way to promote key products to your target audience in supplement or reprint formats. The journal offers the full range of custom services to meet your individual printing requirements, including: Journal Supplements - Rapidly produced (under 12 weeks from acceptance to delivery) and competitively priced, should you wish to sponsor an entire Supplement of new and original research material. All supplements are peer reviewed. Reprints and author offprints - Including customized gloss laminate covers and full printing to requirements, saddle-stitched binding and standard shrink-wrapping at no additional cost. These can be used for: o Sales support materials o Exhibit and meeting handouts o Direct mail inserts o Physician education o Seminar literature o Educational tools o Collections of articles on particular topics o Sponsored subscription opportunities o Translations o Advertising - Including conference listings and related events and launches o Discounts - For multiple orders and advance orders in a one year period.